Drug intelligence / Profile preview

NIKOVIT Q10

Development stage: Unknown
Lead developer: Uniark Healthcare
Modality: Small Molecules
Administration: Oral

Overview

NIKOVIT Q10 is a multi-ingredient nutraceutical formulation marketed by Uniark Healthcare. Its primary active component is Coenzyme Q10 (ubidecarenone), a naturally occurring coenzyme found in the mitochondria of most eukaryotic cells. Coenzyme Q10 plays a critical role in the mitochondrial electron transport chain, where it facilitates aerobic cellular respiration to generate energy in the form of ATP. Additionally, it functions as a potent lipid-soluble antioxidant, protecting cell membranes and lipoproteins from oxidative damage. The product is typically used as a dietary supplement to support cardiovascular health, improve energy levels, and manage conditions associated with oxidative stress.

Brand names: NIKOVIT Q10

Targets

ND1 (Mitochondrial electron transport chain complex I)

Beyond the preview

Go deeper on NIKOVIT Q10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NIKOVIT Q10.

Explore the full profile